Synthetic Peptides Elicit Humoral Response against Porcine Reproductive and Respiratory Syndrome Virus in Swine

The aim of this study was to analyze the immunogenic response elicited in swine by two synthetic peptides derived from GP5 to understand the role of lineal B epitopes in the humoral and B-cell-mediated response against the porcine reproductive and respiratory syndrome virus (PRRSV). For inoculation, twenty-one-day-old pigs were allocated into six groups: control, vehicle, vaccinated (Ingelvac-PRRSV, MLV (R)), non-vaccinated and naturally infected, GP5-B and GP5-B3. At 2 days post-immunization (dpi), the GP5-B3 peptide increased the serum concentrations of cytokines associated with activate adaptive cellular immunity, IL-1 beta (1.15 +/- 1.15 to 10.17 +/- 0.94 pg/mL) and IL-12 (323.8 +/- 23.3 to 778.5 +/- 58.11 pg/mL), compared to the control group. The concentration of IgGs anti-GP5-B increased in both cases at 21 and 42 dpi compared to that at 0 days (128.3 +/- 8.34 ng/mL to 231.9 +/- 17.82 and 331 +/- 14.86 ng/mL), while IgGs anti-GP5-B3 increased at 21 dpi (105.1 +/- 19.06 to 178 +/- 15.09 ng/mL) and remained at the same level until 42 dpi. Also, antibody-forming/Plasma B cells (CD2+/CD21-) increased in both cases (9.85 +/- 0.7% to 13.67 +/- 0.44 for GP5-B and 15.72 +/- 1.27% for GP5-B3). Furthermore, primed B cells (CD2-/CD21+) from immunized pigs showed an increase in both cases (9.62 +/- 1.5% to 24.51 +/- 1.3 for GP5-B and 34 +/- 2.39% for GP5-B3) at 42 dpi. Conversely the na & iuml;ve B cells from immunized pigs decreased compared with the control group (8.84 +/- 0.63% to 6.25 +/- 0.66 for GP5-B and 5.78 +/- 0.48% for GP5-B3). Importantly, both GP5-B and GP5-B3 peptides exhibited immunoreactivity against serum antibodies from the vaccinated group, as well as the non-vaccinated and naturally infected group. In conclusion, GP5-B and GP5-B3 peptides elicited immunogenicity mediated by antigen-specific IgGs and B cell activation.